NDC 64679-759

FUROSEMIDE

Furosemide

FUROSEMIDE is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Wockhardt Usa Llc.. The primary component is Furosemide.

Product ID64679-759_92e617c8-d85a-465d-9ff8-a8c0e110c4c4
NDC64679-759
Product TypeHuman Prescription Drug
Proprietary NameFUROSEMIDE
Generic NameFurosemide
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2007-03-22
Marketing CategoryANDA / ANDA
Application NumberANDA077941
Labeler NameWockhardt USA LLC.
Substance NameFUROSEMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesIncreased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 64679-759-01

25 VIAL, SINGLE-DOSE in 1 CARTON (64679-759-01) > 2 mL in 1 VIAL, SINGLE-DOSE (64679-759-10)
Marketing Start Date2007-03-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64679-759-09 [64679075909]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-22

NDC 64679-759-10 [64679075910]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-03-22

NDC 64679-759-05 [64679075905]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-22

NDC 64679-759-07 [64679075907]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-22

NDC 64679-759-11 [64679075911]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-03-22

NDC 64679-759-01 [64679075901]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-03-22

NDC 64679-759-03 [64679075903]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-03-22

NDC 64679-759-02 [64679075902]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-03-22

NDC 64679-759-12 [64679075912]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-03-22

NDC 64679-759-08 [64679075908]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-22

NDC 64679-759-04 [64679075904]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-22

NDC 64679-759-06 [64679075906]

FUROSEMIDE INJECTION
Marketing CategoryANDA
Application NumberANDA077941
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-03-22

Drug Details

Active Ingredients

IngredientStrength
FUROSEMIDE10 mg/mL

OpenFDA Data

SPL SET ID:b39ad6b3-401d-4aba-a0a9-6d56fcfa0ac9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1719286
  • 1719290
  • 1719291
  • Pharmacological Class

    • Increased Diuresis at Loop of Henle [PE]
    • Loop Diuretic [EPC]

    NDC Crossover Matching brand name "FUROSEMIDE" or generic name "Furosemide"

    NDCBrand NameGeneric Name
    0054-3294FurosemideFurosemide
    0054-3298FurosemideFurosemide
    0054-4297FurosemideFurosemide
    0054-4299FurosemideFurosemide
    0054-4301FurosemideFurosemide
    0054-8297FurosemideFurosemide
    0054-8299FurosemideFurosemide
    0054-8301FurosemideFurosemide
    0378-0208Furosemidefurosemide
    0378-0216Furosemidefurosemide
    0378-0232Furosemidefurosemide
    0404-9861FurosemideFurosemide
    0404-9862FUROSEMIDEfurosemide
    0404-9863FurosemideFurosemide
    0404-9864FUROSEMIDEfurosemide
    0409-1639FurosemideFUROSEMIDE
    0409-6102FUROSEMIDEFUROSEMIDE
    68071-1708FurosemideFurosemide
    68071-1809FurosemideFurosemide
    68071-3273FurosemideFurosemide
    68071-3144FurosemideFurosemide
    68071-3194FurosemideFurosemide
    68071-3148FurosemideFurosemide
    68071-4015FurosemideFurosemide
    68071-4022FurosemideFurosemide
    68071-4349FurosemideFurosemide
    68071-4534FurosemideFurosemide
    0409-9631FurosemideFurosemide
    68071-4445FurosemideFurosemide
    68071-4522FurosemideFurosemide
    68094-867FurosemideFurosemide
    68094-756FurosemideFurosemide
    68788-1966FurosemideFurosemide
    68788-6397FurosemideFurosemide
    68788-6784FurosemideFurosemide
    68788-7265FurosemideFurosemide
    68788-6948FurosemideFurosemide
    68788-9226FurosemideFurosemide
    68788-7354FurosemideFurosemide
    68788-9778FurosemideFurosemide
    69315-116FurosemideFurosemide
    69315-118FurosemideFurosemide
    69315-117FurosemideFurosemide
    69677-204FurosemideFurosemide
    70121-1164FurosemideFurosemide
    70121-1076FurosemideFurosemide
    70121-1163FurosemideFurosemide
    70518-0092FurosemideFurosemide
    70518-0584FurosemideFurosemide
    70518-0120FurosemideFurosemide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.